Chemically modified antisense oligonucleotides for use in rna editing
AssigneeProQR Therapeutics II B.V.
InventorsHáfrun HÁLFDÁNARDÓTTIR, Peggy Ramona BOHLÄNDER, Peter Christian DE VISSER, Marko POTMAN, Sjoerd Johannes RIEKEN
Life of this patent
Estimating the term…